Telehealth provider Karafim launches ‘rapid diagnosis’ process for abortion pills

Reproductive Care Company Decanter Launched a new process aimed at providing immediate access to abortion pills.

Patients living in Illinois, Colorado, New Mexico and Maryland can be tested for drugs without a mandatory telephone or video call. After completing a form on Carafem’s website, the medical staff reviews the patient’s history and shares information about the pill’s usage process and care options.

A medical professional will then approve the prescription, and the pills are sent in the mail, the company said. Patients will also be able to use it. Carathe company’s virtual assistant, which can track deliveries, provide more information about pills and answer questions.

“Abortion should be available to all who want it when they need it, and Carafem’s rapid evaluation for abortion pills is one way to make that a little easier,” said Melissa Grant, Chief Operations Officer and Carafem. Key cofounder said in a statement. “Our medical professionals strive to make abortion services more convenient, personalized and private without compromising high-quality care.”

A big trend

Interest in medication abortion, a The two-shot method used to terminate a pregnancy through 10 weeks’ gestation, increased as a result of the Supreme Court’s Dobbs decision that overturned Roe v. Overturned Wade. one The analysis was published in November. After the draft was leaked and the official announcement of the decision, online requests for access to medicines surged.

Since the FDA approved mifepristone for its use in 2000, the use of abortion pills has also steadily increased. According to the Guttmacher InstituteMore than half of all facility-based abortions in 2020 were medication abortions, up from 39 percent in 2017.

Earlier this month, the FDA said it would Allow retail pharmacies. Before abortion pills were first offered in the U.S., they were only available through some mail-order pharmacies or certified doctors or clinics.

There are anti-abortion groups. Aim bullets faster As more states restrict abortion after Roe. In November, abortion opponents Filed a case in federal court in Texas, arguing that the FDA did not have the authority to approve mifepristone.

Agency Answered the suit In a filing this week, it said “effectively withdrawing from the market a safe and effective drug that has been legally on the market for 22 years would harm the public interest.”

#Telehealth #provider #Karafim #launches #rapid #diagnosis #process #abortion #pills

Leave a Reply

Your email address will not be published. Required fields are marked *